Ethan Lee
-
Vanderbilt researchers identify key molecular driver in aggressive thyroid cancer
Researchers discovered that the protein tenascin-C is a crucial molecular player in the aggressiveness of anaplastic thyroid cancer. The results could lead to better targeted therapeutics for thyroid cancer. Read MoreApr. 3, 2025
-
Lee named 2022 Innovation Fund investigator by The Pew Charitable Trusts
Dr. Ethan Lee, professor of cell and developmental biology and pharmacology, has been named a 2022 Innovation Fund investigator by The Pew Charitable Trusts. As a vote of confidence in the power of collaborative, interdisciplinary research, Pew created the Innovation Fund in 2017 to encourage partnerships among alumni of Pew’s biomedical programs. Combining… Read MoreSep. 28, 2022
-
Faculty awarded Seeding Success Grants for spring 2022
Vanderbilt has awarded 14 faculty members with grants to support the early stages of pioneering research projects identified as likely candidates for further funding from federal, foundation and industry sponsors. The spring 2022 Seeding Success Grants are the second cycle of the internal early investment funding… Read MoreJul. 8, 2022